Global Drug Delivery System Development Services Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06257956

Publication Date:

June 25, 2025

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Drug Delivery System Development Services market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淒rug Delivery System Development Services Industry Forecast鈥� looks at past sales and reviews total world Drug Delivery System Development Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Delivery System Development Services sales for 2025 through 2031. With Drug Delivery System Development Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Delivery System Development Services industry.
This Insight Report provides a comprehensive analysis of the global Drug Delivery System Development Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Delivery System Development Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug Delivery System Development Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Delivery System Development Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Delivery System Development Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Delivery System Development Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oral Drug Delivery System
Transdermal Drug Delivery System
Inhalation Drug Delivery System
Segmentation by Application:
Pharmaceutical Industry
Medical Industry
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD Formulation
Coriolis Pharma
Stevanato Group
ThioMatrix
Creative Biolabs
CMC Pharmaceuticals
Nanopharm Ltd
Adare Pharmaceuticals
AdhexPharma
E3D Elcam Drug Delivery Devices
Alpex Pharma
BD Diagnostics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Delivery System Development Services Market Size (2020-2031)
2.1.2 Drug Delivery System Development Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Drug Delivery System Development Services by Country/Region (2020, 2024 & 2031)
2.2 Drug Delivery System Development Services Segment by Type
2.2.1 Oral Drug Delivery System
2.2.2 Transdermal Drug Delivery System
2.2.3 Inhalation Drug Delivery System
2.3 Drug Delivery System Development Services Market Size by Type
2.3.1 Drug Delivery System Development Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Drug Delivery System Development Services Market Size Market Share by Type (2020-2025)
2.4 Drug Delivery System Development Services Segment by Application
2.4.1 Pharmaceutical Industry
2.4.2 Medical Industry
2.5 Drug Delivery System Development Services Market Size by Application
2.5.1 Drug Delivery System Development Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Drug Delivery System Development Services Market Size Market Share by Application (2020-2025)
3 Drug Delivery System Development Services Market Size by Player
3.1 Drug Delivery System Development Services Market Size Market Share by Player
3.1.1 Global Drug Delivery System Development Services Revenue by Player (2020-2025)
3.1.2 Global Drug Delivery System Development Services Revenue Market Share by Player (2020-2025)
3.2 Global Drug Delivery System Development Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Delivery System Development Services by Region
4.1 Drug Delivery System Development Services Market Size by Region (2020-2025)
4.2 Global Drug Delivery System Development Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug Delivery System Development Services Market Size Growth (2020-2025)
4.4 APAC Drug Delivery System Development Services Market Size Growth (2020-2025)
4.5 Europe Drug Delivery System Development Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Drug Delivery System Development Services Market Size Growth (2020-2025)
5 Americas
5.1 Americas Drug Delivery System Development Services Market Size by Country (2020-2025)
5.2 Americas Drug Delivery System Development Services Market Size by Type (2020-2025)
5.3 Americas Drug Delivery System Development Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Delivery System Development Services Market Size by Region (2020-2025)
6.2 APAC Drug Delivery System Development Services Market Size by Type (2020-2025)
6.3 APAC Drug Delivery System Development Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Delivery System Development Services Market Size by Country (2020-2025)
7.2 Europe Drug Delivery System Development Services Market Size by Type (2020-2025)
7.3 Europe Drug Delivery System Development Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Delivery System Development Services by Region (2020-2025)
8.2 Middle East & Africa Drug Delivery System Development Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Drug Delivery System Development Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Delivery System Development Services Market Forecast
10.1 Global Drug Delivery System Development Services Forecast by Region (2026-2031)
10.1.1 Global Drug Delivery System Development Services Forecast by Region (2026-2031)
10.1.2 Americas Drug Delivery System Development Services Forecast
10.1.3 APAC Drug Delivery System Development Services Forecast
10.1.4 Europe Drug Delivery System Development Services Forecast
10.1.5 Middle East & Africa Drug Delivery System Development Services Forecast
10.2 Americas Drug Delivery System Development Services Forecast by Country (2026-2031)
10.2.1 United States Market Drug Delivery System Development Services Forecast
10.2.2 Canada Market Drug Delivery System Development Services Forecast
10.2.3 Mexico Market Drug Delivery System Development Services Forecast
10.2.4 Brazil Market Drug Delivery System Development Services Forecast
10.3 APAC Drug Delivery System Development Services Forecast by Region (2026-2031)
10.3.1 China Drug Delivery System Development Services Market Forecast
10.3.2 Japan Market Drug Delivery System Development Services Forecast
10.3.3 Korea Market Drug Delivery System Development Services Forecast
10.3.4 Southeast Asia Market Drug Delivery System Development Services Forecast
10.3.5 India Market Drug Delivery System Development Services Forecast
10.3.6 Australia Market Drug Delivery System Development Services Forecast
10.4 Europe Drug Delivery System Development Services Forecast by Country (2026-2031)
10.4.1 Germany Market Drug Delivery System Development Services Forecast
10.4.2 France Market Drug Delivery System Development Services Forecast
10.4.3 UK Market Drug Delivery System Development Services Forecast
10.4.4 Italy Market Drug Delivery System Development Services Forecast
10.4.5 Russia Market Drug Delivery System Development Services Forecast
10.5 Middle East & Africa Drug Delivery System Development Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Drug Delivery System Development Services Forecast
10.5.2 South Africa Market Drug Delivery System Development Services Forecast
10.5.3 Israel Market Drug Delivery System Development Services Forecast
10.5.4 Turkey Market Drug Delivery System Development Services Forecast
10.6 Global Drug Delivery System Development Services Forecast by Type (2026-2031)
10.7 Global Drug Delivery System Development Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Drug Delivery System Development Services Forecast
11 Key Players Analysis
11.1 CD Formulation
11.1.1 CD Formulation Company Information
11.1.2 CD Formulation Drug Delivery System Development Services Product Offered
11.1.3 CD Formulation Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 CD Formulation Main Business Overview
11.1.5 CD Formulation Latest Developments
11.2 Coriolis Pharma
11.2.1 Coriolis Pharma Company Information
11.2.2 Coriolis Pharma Drug Delivery System Development Services Product Offered
11.2.3 Coriolis Pharma Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Coriolis Pharma Main Business Overview
11.2.5 Coriolis Pharma Latest Developments
11.3 Stevanato Group
11.3.1 Stevanato Group Company Information
11.3.2 Stevanato Group Drug Delivery System Development Services Product Offered
11.3.3 Stevanato Group Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Stevanato Group Main Business Overview
11.3.5 Stevanato Group Latest Developments
11.4 ThioMatrix
11.4.1 ThioMatrix Company Information
11.4.2 ThioMatrix Drug Delivery System Development Services Product Offered
11.4.3 ThioMatrix Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ThioMatrix Main Business Overview
11.4.5 ThioMatrix Latest Developments
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Information
11.5.2 Creative Biolabs Drug Delivery System Development Services Product Offered
11.5.3 Creative Biolabs Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Creative Biolabs Main Business Overview
11.5.5 Creative Biolabs Latest Developments
11.6 CMC Pharmaceuticals
11.6.1 CMC Pharmaceuticals Company Information
11.6.2 CMC Pharmaceuticals Drug Delivery System Development Services Product Offered
11.6.3 CMC Pharmaceuticals Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 CMC Pharmaceuticals Main Business Overview
11.6.5 CMC Pharmaceuticals Latest Developments
11.7 Nanopharm Ltd
11.7.1 Nanopharm Ltd Company Information
11.7.2 Nanopharm Ltd Drug Delivery System Development Services Product Offered
11.7.3 Nanopharm Ltd Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Nanopharm Ltd Main Business Overview
11.7.5 Nanopharm Ltd Latest Developments
11.8 Adare Pharmaceuticals
11.8.1 Adare Pharmaceuticals Company Information
11.8.2 Adare Pharmaceuticals Drug Delivery System Development Services Product Offered
11.8.3 Adare Pharmaceuticals Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Adare Pharmaceuticals Main Business Overview
11.8.5 Adare Pharmaceuticals Latest Developments
11.9 AdhexPharma
11.9.1 AdhexPharma Company Information
11.9.2 AdhexPharma Drug Delivery System Development Services Product Offered
11.9.3 AdhexPharma Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 AdhexPharma Main Business Overview
11.9.5 AdhexPharma Latest Developments
11.10 E3D Elcam Drug Delivery Devices
11.10.1 E3D Elcam Drug Delivery Devices Company Information
11.10.2 E3D Elcam Drug Delivery Devices Drug Delivery System Development Services Product Offered
11.10.3 E3D Elcam Drug Delivery Devices Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 E3D Elcam Drug Delivery Devices Main Business Overview
11.10.5 E3D Elcam Drug Delivery Devices Latest Developments
11.11 Alpex Pharma
11.11.1 Alpex Pharma Company Information
11.11.2 Alpex Pharma Drug Delivery System Development Services Product Offered
11.11.3 Alpex Pharma Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Alpex Pharma Main Business Overview
11.11.5 Alpex Pharma Latest Developments
11.12 BD Diagnostics
11.12.1 BD Diagnostics Company Information
11.12.2 BD Diagnostics Drug Delivery System Development Services Product Offered
11.12.3 BD Diagnostics Drug Delivery System Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 BD Diagnostics Main Business Overview
11.12.5 BD Diagnostics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂